David Gionco, Group VP & Chief Acct. Officer at SAVIENT PHARMACEUTICALS INC (SVNT), sold 1,560 shares at $0.93 ($1K) on 2013-03-06, disclosed to the SEC on 2013-03-08.
Scheduled sale ($1k) by Group VP & Chief Acct. Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| STML | SELL | 2020-03-13 | $69K | — | Filing → |
| STML | SELL | 2020-02-28 | $118K | — | Filing → |
| STML | SELL | 2020-01-03 | $49K | — | Filing → |